No subgroups of patients with higher treatment effects have been clearly detected in multiple sclerosis (MS). The aim of the present work was to evaluate whether there are subgroups of relapsing-remitting MS (RRMS) patients who are more responsive to treatments.
Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials
SIGNORI, ALESSIO;SCHIAVETTI, IRENE;GALLO, FABIO;SORMANI, MARIA PIA
2015-01-01
Abstract
No subgroups of patients with higher treatment effects have been clearly detected in multiple sclerosis (MS). The aim of the present work was to evaluate whether there are subgroups of relapsing-remitting MS (RRMS) patients who are more responsive to treatments.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
signori2015.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
633.94 kB
Formato
Adobe PDF
|
633.94 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
